| Application no. and date | 18178602.1 (espacenet) (Federated) (European Patent Register), 20101122 | | Patent/reg. no. and date | DK/EP 3415515, 20191225 | | Publication date | 20181219 | | Priority no. and date | EP 09177371, 20091127 | | EP pub. no. and date |
EP 3415515 20181219 | | Effective date | | | Applicant/owner | Adverio Pharma GmbH, Kaiser-Wilhelm-Allee 1
51373 Leverkusen, DE | | Applicant ref. no. | 1522412 | | Inventor | REHSE, Joachim, Am Kloster 12
42799 Leichlingen, DE,
MAIS, Franz-Josef, Otto-Hahn-Str. 164
40591 Düsseldorf, DE,
SIEGEL, Konrad, Augsburgerstrasse 11
40597 Düsseldorf, DE,
Joentgen, Winfried, Sprengelstrasse 1
50735 Köln, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07D 471/04 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF METHYL-{4,6-DIAMINO-2-[1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL}METHYLCARBAMAT | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
